Cargando…

Regression of Liver Steatosis Following Phosphatidylcholine Administration: A Review of Molecular and Metabolic Pathways Involved

Liver steatosis is a key pathology in non-alcoholic or metabolic associated fatty liver disease. Though largely ignored for decades it is currently becoming the focus of research in hepatology. It is important to consider its origin and current opportunities in terms of pharmacotherapy. Essential ph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osipova, D., Kokoreva, K., Lazebnik, L., Golovanova, E., Pavlov, Ch., Dukhanin, A., Orlova, S., Starostin, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960636/ https://www.ncbi.nlm.nih.gov/pubmed/35359878 http://dx.doi.org/10.3389/fphar.2022.797923

Ejemplares similares

Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study)
por: Maev, Igor V, et al.
Publicado: (2020)

A New, Non-Invasive Scale for Steatosis Developed Using Real-World Data From Russian Outpatients to Aid in the Diagnosis of Non-Alcoholic Fatty Liver Disease
por: Maev, Igor V., et al.
Publicado: (2020)

Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia
por: Maev, Igor V, et al.
Publicado: (2020)

Real-world comorbidities and treatment patterns among patients with non-alcoholic fatty liver disease receiving phosphatidylcholine as adjunctive therapy in Russia
por: Maev, Igor V, et al.
Publicado: (2019)

Decreasing Phosphatidylcholine on the Surface of the Lipid Droplet Correlates with Altered Protein Binding and Steatosis
por: Listenberger, Laura, et al.
Publicado: (2018)

Alcohol Abstinence Rescues Hepatic Steatosis and Liver Injury via Improving Metabolic Reprogramming in Chronic Alcohol-Fed Mice
por: Pi, Aiwen, et al.
Publicado: (2021)

Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism
por: Qiao, Xin, et al.
Publicado: (2019)

Immune and Metabolic Regulation Mechanism of Dangguiliuhuang Decoction against Insulin Resistance and Hepatic Steatosis
por: Cao, Hui, et al.
Publicado: (2017)

Protective Effect of Isoorientin on Oleic Acid-Induced Oxidative Damage and Steatosis in Rat Liver Cells
por: Luo, Tongwang, et al.
Publicado: (2022)

Ginsenoside Rb1 Alleviates Alcohol-Induced Liver Injury by Inhibiting Steatosis, Oxidative Stress, and Inflammation
por: Lai, Yuqi, et al.
Publicado: (2021)

Prevention and regression of megamitochondria and steatosis by blocking mitochondrial fusion in the liver
por: Yamada, Tatsuya, et al.
Publicado: (2022)

New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease
por: López-Riera, Mireia, et al.
Publicado: (2017)

Atractyloside Protect Mice Against Liver Steatosis by Activation of Autophagy via ANT-AMPK-mTORC1 Signaling Pathway
por: Zhang, Pengfei, et al.
Publicado: (2021)

Liraglutide Alleviates Hepatic Steatosis and Liver Injury in T2MD Rats via a GLP-1R Dependent AMPK Pathway
por: Zhou, Rui, et al.
Publicado: (2021)

Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and in vivo experimental validation
por: Lei, Sisi, et al.
Publicado: (2022)

Phosphatidylcholine Membrane Fusion Is pH-Dependent
por: Akimov, Sergey A., et al.
Publicado: (2018)

Development of a novel human triculture model of non-alcoholic fatty liver disease and identification of berberine as ameliorating steatosis, oxidative stress and fibrosis
por: Rafiei, Hossein, et al.
Publicado: (2023)

Phosphatidylcholine (18:0/20:4), a potential biomarker to predict ethionamide‐induced hepatic steatosis in rats
por: Muta, Kyotaka, et al.
Publicado: (2022)

Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission
por: Volkova, Anastasiya, et al.
Publicado: (2016)

Kaempferol Alleviates Steatosis and Inflammation During Early Non-Alcoholic Steatohepatitis Associated With Liver X Receptor α-Lysophosphatidylcholine Acyltransferase 3 Signaling Pathway
por: Xiang, Hongjiao, et al.
Publicado: (2021)

Protective Effect of Patchouli Alcohol Against High-Fat Diet Induced Hepatic Steatosis by Alleviating Endoplasmic Reticulum Stress and Regulating VLDL Metabolism in Rats
por: Wu, Xue, et al.
Publicado: (2019)

Zinc Oxide Nanoparticle Caused Plasma Metabolomic Perturbations Correlate with Hepatic Steatosis
por: Zhang, Weidong, et al.
Publicado: (2018)

Secondhand Smoke Induces Liver Steatosis through Deregulation of Genes Involved in Hepatic Lipid Metabolism
por: Tommasi, Stella, et al.
Publicado: (2020)

Mitotherapy for Fatty Liver by Intravenous Administration of Exogenous Mitochondria in Male Mice
por: Fu, Ailing, et al.
Publicado: (2017)

miR-203 Inhibits Alcohol-Induced Hepatic Steatosis by Targeting Lipin1
por: Cheng, Xiao-Yu, et al.
Publicado: (2018)

Mitochondrial Energy-Regulating Effect of Atractyloside Inhibits Hepatocellular Steatosis Through the Activation of Autophagy
por: Zhang, Pengfei, et al.
Publicado: (2020)

Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway
por: Li, Liuran, et al.
Publicado: (2021)

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
por: Wang, Zeneng, et al.
Publicado: (2011)

Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice
por: Ardaiz, Nuria, et al.
Publicado: (2021)

Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro
por: Li, Ting, et al.
Publicado: (2021)

Metformin Alleviates Hepatic Steatosis and Insulin Resistance in a Mouse Model of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Promoting Transcription Factor EB-Dependent Autophagy
por: Zhang, Dan, et al.
Publicado: (2021)

Fenofibrate Improves Insulin Resistance and Hepatic Steatosis and Regulates the Let-7/SERCA2b Axis in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice
por: Zhang, Dan, et al.
Publicado: (2022)

Liver Steatosis: A Marker of Metabolic Risk in Children
por: Neri, Costanza Renata, et al.
Publicado: (2022)

Enzymatic extraction and functional properties of phosphatidylcholine from chicken liver
por: Huang, Jin, et al.
Publicado: (2021)

Structural Characterization of Peptides From Huangjiu and Their Regulation of Hepatic Steatosis and Gut Microbiota Dysbiosis in Hyperlipidemia Mice
por: Shi, Ying, et al.
Publicado: (2021)

Ibogaine Administration Modifies GDNF and BDNF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits
por: Marton, Soledad, et al.
Publicado: (2019)

Involvement of endoplasmic reticulum stress in rifampicin-induced liver injury
por: Hou, Wanqing, et al.
Publicado: (2022)

Phosphatidylcholine Metabolic Transformation and Progression Signature as a Pharmacodynamic Biomarker
por: Aboagye, Eric O.
Publicado: (2010)

Analyzing the metabolic fate of oral administration drugs: A review and state-of-the-art roadmap
por: Liu, Liu, et al.
Publicado: (2022)

Polyacetylene From Dendropanax morbifera Alleviates Diet-Induced Obesity and Hepatic Steatosis by Activating AMPK Signaling Pathway
por: Kang, Myung-Ji, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4ovk545h4oo0lu6c0de9iv7sdl